ReviewCancers2025

Topical 5% Imiquimod for the Treatment of Superficial and Nodular Periocular Basal Cell Carcinoma: A Systematic Review of Clinical Outcomes, Safety, and Treatment Strategies.

Larysa Krajewska-Węglewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.